Jhulan Mukharji
Cardiovascular Disease · Shawnee Mission, KSNPI 1154320414
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $699 and has fallen 60.2% since, to $278 in 2023. That places this record below the midpoint for cardiovascular disease clinicians in KS, where the typical reported total is $2,383.
Across 120 payments — averaging $18.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$476
- Amgen$452
- Pfizer$172
- Boston Scientific$168
- Merck$144
- Actelion Pharmaceuticals US, Inc.$109
- plus $646 from 14 others
What the payments were for
- Food & beverage$2,167100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 28 | $476 |
| Amgen | 22 | $452 |
| Pfizer | 12 | $172 |
| Boston Scientific | 3 | $168 |
| Merck | 9 | $144 |
| Actelion Pharmaceuticals US, Inc. | 6 | $109 |
| AstraZeneca | 6 | $99 |
| Sanofi-aventis U.S. LLC | 6 | $90 |
| Amarin Pharma, Inc. | 6 | $89 |
| Novartis | 5 | $70 |
| E.r. Squibb & Sons, L.L.C. | 4 | $61 |
| Bayer | 3 | $53 |
| Alnylam Pharmaceuticals Inc. | 2 | $39 |
| Abbott | 1 | $25 |
| Penumbra, Inc. | 2 | $23 |
| Atricure, Inc. | 1 | $21 |
| Novo Nordisk | 1 | $21 |
| Cvrx, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Irhythm Technologies, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$139
- Repatha$126
How this compares
$2,167 in reported general payments places this provider in the 45th percentile of 175 cardiovascular disease providers in Kansas.
Other cardiovascular disease in Shawnee Mission
- Bassem ChehabWichita$482K
- Vasvi SinghOverland Park$405K
- Joseph GalichiaWichita$177K
- Wassim ShaheenWichita$137K
- Layne ReusserWichita$91K
- Aziz MaksoudWichita$81K
- Mildred OpondoHays$59K
- Rachel SoslandOverland Park$33K
- Ahmed ElballatOverland Park$22K
- Timothy BeaverKansas City$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.